Arja Ray (@rayarja) 's Twitter Profile
Arja Ray

@rayarja

Postdoc in tumor immunology @MaxKrummel lab. PhD in cell migration, ECM, metastasis @ppproven lab. Occasional Writing @ convergentlines.blogspot.com

ID: 1256736242227531777

linkhttp://www.arjaraylab.com calendar_today03-05-2020 00:04:21

273 Tweet

250 Followers

218 Following

Andrew Beam (@andrewlbeam) 's Twitter Profile Photo

1/n: We are excited to share that our paper on Chroma, a general purpose diffusion model for proteins, is out today in nature! nature.com/articles/s4158… A couple of my favorite highlights in the 🧵below 👇

Mackay Lab (@lmackaylab) 's Twitter Profile Photo

🌟Excited to share our latest work on how functionally distinct skin TRM utilise different pathways to establish residency, published today in Science Magazine! A true labour of love by BFF Simone Park and Susan Christo! 👩‍🔬 Doherty Institute University of Melbourne UniMelb MDHS science.org/doi/10.1126/sc…

JCBeltra (@beltrajc) 's Twitter Profile Photo

Our latest story is out in @CellPressImmunity today!! We show that Stat5 opposes Tox and rewires exhausted CD8s towards more durably protective effector-like states. Shout out to my co-authors, Parker Institute for Cancer Immunotherapy and E. John Wherry Key take-home messages in the 🧵⬇️ cell.com/immunity/ppt/S…

Our latest story is out in @CellPressImmunity today!! We show that Stat5 opposes Tox and rewires exhausted CD8s towards more durably protective effector-like states. Shout out to my co-authors, <a href="/parkerici/">Parker Institute for Cancer Immunotherapy</a> and <a href="/EJohnWherry/">E. John Wherry</a>
Key take-home messages in the 🧵⬇️
cell.com/immunity/ppt/S…
Miriam Merad, MD, PhD (@miriammerad) 's Twitter Profile Photo

Hope you can join Max and I at the keystone meeting we have organized on Myeloid Targeting Strategies for Cancer Treatment, this May in Killarney! keysym.us/KSMyeloidTarge… #KSMyeloidTargets24

Hope you can join <a href="/MaxKrummel/">Max</a> and I at the keystone meeting we have organized on Myeloid Targeting Strategies for Cancer Treatment, this May in Killarney! keysym.us/KSMyeloidTarge… #KSMyeloidTargets24
Jaehyuk Choi (@jaehyukchoimd) 's Twitter Profile Photo

T cell lymphoma mutations power adoptive T cell therapies! Excited to see this published! A true collaboration with friend and colleague @koleroybal and our students @jay__daniels and #julie_garcia. nature.com/articles/s4158…

E. John Wherry (@ejohnwherry) 's Twitter Profile Photo

Huge congrats to Cathy Wu for the Sjöberg Prize and wonderful coverage today on CNN. Very well-deserved. Cathy is a truly groundbreaking scientist and also exceptional human being. Bringing more immunology to more cancer patients. cnn.com/2024/02/20/hea…

Kartik Sunagar (@anaturalist) 's Twitter Profile Photo

Our paper on the cover of Science Translational Medicine! What's more, it features my photograph of a cobra from our beautiful IISc Bangalore This is a collab with Jardine lab at Scripps Research, Centre for Snakebite Research & Interventions, et al. Takes us 1 step closer to Universal antivenom for treating snakebite Evolutionary Venomics Lab

Mikala Egeblad (@megeblad) 's Twitter Profile Photo

We found that chronic stress increases metastasis in mice. The neutrophils are at the helm (again!). Link to our report in Cancer Cell: authors.elsevier.com/a/1ieO05TA51hO…

Fareed Zakaria (@fareedzakaria) 's Twitter Profile Photo

A deeply moving memoir of an enchanting person I first met a few days after she was born. Thank you ⁦David Frum⁩ theatlantic.com/magazine/archi…

Adam Kolom (@adamksay) 's Twitter Profile Photo

Crazy—we took a quick look at our platform data to see if it supported how it "feels" out there. 2024 is on trend for the lowest programs against "new drug targets" in ~30 years. This kind of risk aversion very bad for future patients, especially with so much strong new

Crazy—we took a quick look at our platform data to see if it supported how it "feels" out there. 2024 is on trend for the lowest programs against "new drug targets" in ~30 years. This kind of risk aversion very bad for future patients, especially with so much strong new